Current status and prospect of treatments for recurrent hepatocellular carcinoma

Table 2 Overall survival and recurrence-free survival after salvage transplantation for recurrent hepatocellular carcinoma

Ref.	Type	Years	n	1-, 3-, and 5-yr OS	1-, 3-, and 5-yr RFS
Guerrini et al[174]	Retrospective	2000-2011	28	-/-/42%	N/A
Chan et al[175]	Retrospective	2005-2017	776	96%/75%/67%	89%/68%/68%
Chan et al[176]	Retrospective	1993-2009	19	-/-/50%	68%/58%/58%
Bhangui et al[177]	Prospective	-	31	-/-/54%	-/-/48%
Shan et al[178]	Retrospective	2006-2015	45	65%/53%/42%	48%/32%/32%
Liu et al[179]	Retrospective	2001-2011	39	88%/78%/61%	14%/24%/33%
Hu et al[180]	Retrospective	1999-2009	888	73%/52%/46%	N/A
Wang et al[181]	Prospective	2001-2013	74	88%/79%/62%	87%/74%/67%

OS: Overall survival; RFS: Recurrence-free survival; HCC: Hepatocellular carcinoma; N/A: Not applicable.